医药前沿
醫藥前沿
의약전연
Yiayao Qianyan
2015年
29期
9-10
,共2页
成英%邓新宇%薛青%焦维克
成英%鄧新宇%薛青%焦維剋
성영%산신우%설청%초유극
肺癌%肺部感染%临床分析%抗生素
肺癌%肺部感染%臨床分析%抗生素
폐암%폐부감염%림상분석%항생소
Lung cancer%Pulmonary infection%Clinical analysis%Antibiotics
目的：通过对住院肺癌患者病例调查，了解肺癌患者发生肺部感染易感因素、病原菌特点及耐药性等，为肺癌患者肺部感染的诊断和治疗提供依据。方法：对2013年1月至2014.12月期间收住院的126例确诊肺癌患者临床资料进行回顾性分析。结果：126例肺癌患者中合并有肺部感染者69例，发生率为54.76%，以革兰氏阴性菌感染为主，占59.1%。结论：肺癌患者合并肺部感染较为常见，应及早诊断、合理治疗，改善患者生存治疗。
目的：通過對住院肺癌患者病例調查，瞭解肺癌患者髮生肺部感染易感因素、病原菌特點及耐藥性等，為肺癌患者肺部感染的診斷和治療提供依據。方法：對2013年1月至2014.12月期間收住院的126例確診肺癌患者臨床資料進行迴顧性分析。結果：126例肺癌患者中閤併有肺部感染者69例，髮生率為54.76%，以革蘭氏陰性菌感染為主，佔59.1%。結論：肺癌患者閤併肺部感染較為常見，應及早診斷、閤理治療，改善患者生存治療。
목적：통과대주원폐암환자병례조사，료해폐암환자발생폐부감염역감인소、병원균특점급내약성등，위폐암환자폐부감염적진단화치료제공의거。방법：대2013년1월지2014.12월기간수주원적126례학진폐암환자림상자료진행회고성분석。결과：126례폐암환자중합병유폐부감염자69례，발생솔위54.76%，이혁란씨음성균감염위주，점59.1%。결론：폐암환자합병폐부감염교위상견，응급조진단、합리치료，개선환자생존치료。
Objective To analyze the present with lung cancer,so as to understand the susceptible factors, pathogenic bacteria characteristics and drug resistance of pulmonary infection in patients with lung cancer, and provide evidence for the diagnosis and treatment of pulmonary infection in patients with lung cancer.Methods The clinical data of 126 lung cancer patients were selected from January 2013 to 2014.12 months in our hospita1.were retrospectively analyzed.Results There were 69 cases of lung cancer patients with pulmonary infection, the incidence of 54.76%, gram negative bacteria infection, accounting for 59.1%.Conclusion Pulmonary infection of patients with lung cancer is common, should be diagnosed early, reasonable treatment, improve the survival and treatment of patients.
